A case report of toxic epidermal necrolysis associated with AZD-9291.

Author: ChengXianYe, LuYan, WangJie, ZhouBingRong

Paper Details 
Original Abstract of the Article :
Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are a strain of small molecule inhibitors mainly used to treat the metastatic non-small cell lung cancer. Their predominant adverse effect is skin toxicity, usually manifested as acneiform rash, skin fissure, xerosis, and parony...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047856/

データ提供:米国国立医学図書館(NLM)

Toxic Epidermal Necrolysis: A Rare and Severe Side Effect of AZD-9291

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), like a powerful desert wind, target specific pathways involved in cancer growth. While these drugs are generally effective, they can sometimes cause severe side effects. This case report highlights a rare and serious side effect of AZD-9291, a new generation EGFR-TKI, known as toxic epidermal necrolysis (TEN), a life-threatening skin reaction.

A Warning Sign: Toxic Epidermal Necrolysis

The patient developed widespread skin necrosis and was diagnosed with TEN after taking AZD-9291. This case serves as a reminder that even with advanced therapies, potential adverse effects must be carefully monitored. It's like navigating a treacherous desert landscape, where unexpected dangers can lurk even amidst the most promising oases.

Understanding the Risks and Benefits

This case report emphasizes the importance of understanding the potential risks and benefits of any medication. It highlights the need for vigilant monitoring and prompt intervention in case of severe reactions. Imagine a wise desert guide, equipped with knowledge and experience, ensuring the safety of those venturing into the unknown.

Dr. Camel's Conclusion

This case report serves as a valuable reminder that even with the advent of new and innovative therapies, vigilant monitoring for adverse effects is essential. By understanding the risks and benefits of each treatment, we can best navigate the complex landscape of medicine and provide optimal care for our patients.
Date :
  1. Date Completed 2018-12-11
  2. Date Revised 2022-06-03
Further Info :

Pubmed ID

30034220

DOI: Digital Object Identifier

PMC6047856

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.